Increased final adult height by gonadotropin-releasing hormone agonist in girls with idiopathic central precocious puberty.
Hae Sang LeeJong Seo YoonKyu Jung ParkJin Soon HwangPublished in: PloS one (2018)
FAH was significantly higher than the initial PAH in girls with CPP who were treated with GnRHa. Also, GnRHa treatment was still effective even after 8 years of age in girls with CPP.